Outcomes of 138 myelodysplastic syndrome patients with HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation

Qian-Qian WANG; Zi-Xian LIU; Xiao-Li ZHAO; Gui-Xin ZHANG; Jian-Feng YAO; Xiao-Hui ZHENG; Li-Ning ZHANG; Yu-Yan SHEN; Xing-Li ZHAO; Yi HE; Yong HUANG; Rong-Li ZHANG; Jia-Lin WEI; Qiao-Ling MA; Ai-Ming PANG; Dong-Lin YANG; Wei-Hua ZHAI; Er-Lie JIANG; Si-Zhou FENG; Ming-Zhe HAN.
Chinese Journal of Hematology ; (12): 132-137, 2020.
Artículo en Zh | WPRIM | ID: wpr-1012157

Documentos relacionados

  1. [Outcomes of 138 myelodysplastic syndrome patients with HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation].
  2. HIV-1 remission and possible cure in a woman after haplo-cord blood transplant.
  3. Maintenance therapy in acute myeloid leukemia: advances and controversies.
  4. Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML.
  5. Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.
  6. Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.
  7. Cancer stem cells: The adventurous journey from hematopoietic to leukemic stem cells.
  8. Aging and comprehensive molecular profiling in acute myeloid leukemia.
  9. [Analysis of the characteristics of primary acute myeloid leukemia with 11q23/KMT2A rearrangements in ninety patients].
  10. Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.